Systematic evaluation of CrRNA design parameters for optimized Cas13d-mediated RNA targeting in chicken cells

Emily Hann1,2, Debolina Majumdar1, Daniel Layton1

  • 1Australian Centre for Disease Preparedness, CSIRO Health and Biosecurity, Geelong, VIC, Australia.

PubMed

Insights

This study details effective CRISPR-Cas13 RNA targeting by optimizing crRNA design, revealing high tolerance for single mismatches but reduced efficacy with four or more. This advances RNA silencing applications.

Area of Science:

  • Molecular Biology
  • RNA Targeting
  • Gene Editing Technologies

Background:

  • CRISPR-Cas13 systems offer programmable RNA targeting for gene silencing.
  • Understanding the molecular basis of Cas13 activity is crucial for its application.
  • Current limitations exist due to incomplete knowledge of on-target and collateral effects.

Purpose of the Study:

  • To establish principles for designing effective CRISPR-Cas13 RNA targeting crRNAs.
  • To investigate factors influencing RfxCas13d crRNA efficacy, including length, flanking sequences, and mismatch tolerance.
  • To compare the targeting and collateral activity of RfxCas13d and HfCas13d variants.

Main Methods:

  • Systematic evaluation of crRNA design parameters for RfxCas13d.
  • Testing crRNA efficacy against DsRed fluorescence reporter and synthetic influenza mRNA in chicken DF1 cells.
  • Assessing the impact of single-nucleotide and multi-nucleotide mismatches on targeting efficiency.
  • Comparing the performance of RfxCas13d and HfCas13d in RNA targeting and collateral activity.

Main Results:

  • Several designed crRNAs achieved over 95% target RNA knockdown.
  • CRISPR-Cas13 crRNAs demonstrated high tolerance to single-nucleotide mismatches.
  • Four-nucleotide mismatches significantly reduced targeting efficacy, while eight-nucleotide mismatches abolished activity.
  • Variable knockdown levels were observed, highlighting the importance of crRNA design.

Conclusions:

  • Established principles for rational crRNA design to optimize CRISPR-Cas13d RNA targeting.
  • Demonstrated high mismatch tolerance but sensitivity to larger mismatches in Cas13d systems.
  • Provided insights into Cas13d-mediated RNA targeting, enhancing its utility in applications like antiviral strategies.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...